Monoclonal Antibody Therapy: The NJ Experience with COVID-19 – A Panel Discussion

Monoclonal Antibody Therapy: The NJ Experience with COVID-19 – A Panel Discussion

Dr. Marc J. Levine, Director, Orthopedic Spine Surgery, RWJUH Hamilton; Immediate Past President, MSNJ (Panel Moderator)

Join the Medical Society of New Jersey (MSNJ) for a Webinar: Monoclonal Antibody Treatment Panel Discussion – The NJ Experience with COVID-19 on Wednesday, March 24, 2021 at 7:00pm via Zoom. Moderated by Marc J. Levine, MD, Director, Orthopedic Spine Surgery, RWJUH Hamilton, and Immediate Past President, MSNJ

Presentations:

– Recent History and Pharmacology of Monoclonal Antibody Therapy –

Lewis S. Nelson, MD, Professor and Chair, Department of Emergency Medicine, Rutgers New Jersey Medical School

Learn how it works, how it is made, how it is administered, what setting it is administered in, how long it takes to administer and how you judge if it is working.

– Benefits and Side Effects of Monoclonal Antibody Treatment –

Rohan Somar, MD, MBA, CPE, FACEP, FAAEM, Chairman, Department of Emergency Medicine at Saint Clare’s Health System

Learn about the efficacy, side effects, data, difference between mono-clonal antibodies, Bamlavivimab, Etesvimab and combination treatments (glucocorticoids).

– Patient Eligibility –

Christopher F. Freer, DO, FACEP, Senior Vice President of Emergency and Hospitalist Medicine at RWJBarnabas Health

Learn who can get the antibody treatment, who is considered at high risk and able to get treatment, pregnant/breastfeeding considerations, who should not get treatment and how you refer a patient for monoclonal AB treatment—who makes determination.

Register Here

Tags webinar